Redeye provides an update following Jumpgate’s Q1 2025 report. The results were broadly in line with expectations, with no major surprises. We view the recent activities positively, particularly the additions to the project pipeline. Following the report, we have made minor revisions to our near-term estimates and fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/